IRCT201105311179N5已完成未知
The effect of combination therapy with Ezetimibe and Gemfibrozile on post-prandial hypertriglyceridemia in type 2 Diabetic patients
Zanjan Metabolic Research Center, Zanjan University of medical science0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 65 years（—）
- 性别
- All
入选标准
- •The average age of 20-65-HbA1C <8%-hypertriglycemia>250mg/dl?Patients with DM type 2
- •Exclusion criteria:
- •Treating with antilipid agents, thyroid disease, acute or chronic liver disease, association with other endocrine disease like Acromegaly or cushing , renal dysfunction (GFR<60), Hypertriglyceridemia>1000 and LDL >190mg/dl
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Effects of ezetimibe combination therapy for patients with atherosclerotic cardiovascular disease; randomized comparison of LDL-cholesterol targeting <70 versus <55mg/dL; Ez-PAVE trialDiseases of the circulatory systemKCT0005547Yonsei University Health System, Severance Hospital3,048
未知
4 期
Effect of ezetimibe/statin combination therapy in patients with type 2 diabetes and dyslipidemia on remnant and inflammatioJPRN-UMIN000002318Kobe University Graduate School of Medicine, Division of Diabetes, Metabolism and Endocrinology100
招募中
4 期
Clinical research on concurrent therapy of Ezetimibe and StatiCoronary artery disease or diabeticJPRN-UMIN000003168Tokushima Red Cross Hospital200
已完成
不适用
A study on efficacy of Ezetimibe in patients with Dyslipidemia associated with Digestive disease-Its effect on biliary bigly metabolismhypercholesterolemiaJPRN-UMIN000004183Hiroshima University hospital Department of General Medicine60
已完成
3 期
Therapeutic fficacy of ezetimibe in patients with nonalcoholic steatohepatitis (NASH): a pilot study.onalcoholic steatohepatitis (NASH)JPRN-UMIN000001258Division of Gastroenterology, Yokohama City University Hospital10